Infectious Disease Research Institute (IDRI) and Medicago, Inc. Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
4/18/2013 9:23:50 AM
More...
|
Infectious Disease Research Institute (IDRI) and Medicago, Inc. to Present Data at the World Vaccine Congress
4/9/2013 6:48:19 AM
More...
|
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine With GLA Adjuvant
8/16/2012 10:20:05 AM
More...
|
Infectious Disease Research Institute (IDRI) Expands Board, Adding Additional International Expertise With Dr Massimo Radaelli
7/3/2012 9:59:17 AM
More...
|
Soligenix (SNGX.OB) Announces Collaboration with Infectious Disease Research Institute (IDRI) to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
6/27/2012 9:40:52 AM
More...
|
Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters
5/31/2012 11:10:18 AM
More...
|
Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine
5/10/2012 10:06:47 AM
More...
|
Infectious Disease Research Institute (IDRI) Quest for Leprosy Vaccine Closer to Reality With Help of Million Dollar Grant
3/8/2012 11:00:37 AM
More...
|
Infectious Disease Research Institute (IDRI) Release: First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial
2/23/2012 10:26:23 AM
More...
|
Infectious Disease Research Institute (IDRI) Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial
2/1/2012 10:07:36 AM
More...
|
|